NCT06041399 is a Phase 4 clinical trial of hypoglycemic Agents(metformin) in Diabetic Peripheral Neuropathy, sponsored by First Affiliated Hospital of Wenzhou Medical University.

Who is sponsoring NCT06041399?

NCT06041399 is sponsored by First Affiliated Hospital of Wenzhou Medical University.

What drugs are being tested in NCT06041399?

Interventions in NCT06041399: hypoglycemic Agents(metformin), lipid-lowering drug(Statin).

What condition does NCT06041399 study?

NCT06041399 studies Diabetic Peripheral Neuropathy.

Is NCT06041399 still recruiting?

NCT06041399 is currently status unknown. Last updated 18 September 2023.

Last reviewed 2023-09-18 · How we verify

NCT06041399

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

Status unknown Phase 4 Last updated 18 September 2023

What this trial tests

Phase 4 trial testing hypoglycemic Agents(metformin) in Diabetic Peripheral Neuropathy in 1,400 participants. Status unknown.

Timeline

1 February 2012

Primary endpoint
18 December 2022

2 January 2025

Quick facts

Lead sponsor	First Affiliated Hospital of Wenzhou Medical University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	1,400
Start date	1 February 2012
Primary completion	18 December 2022
Estimated completion	2 January 2025
Sites	1 location across China

Drugs / interventions tested

hypoglycemic Agents(metformin) — full drug profile →
lipid-lowering drug(Statin) — full drug profile →

Conditions studied

Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Who can join

Eligibility, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
NCT06591780 — Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy · NA · recruiting
NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting

Other First Affiliated Hospital of Wenzhou Medical University trials

Trials by the same sponsor.

NCT07394205 — Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Can · EARLY_PHASE1 · not yet recruiting
NCT07179120 — Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm · Phase 2 · not yet recruiting
NCT07495735 — Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellula · not yet recruiting
NCT07381634 — The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities · Phase 2 · not yet recruiting
NCT07284524 — Intelligent Precision Knee Preservation System for Knee Osteoarthritis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06041399 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Wenzhou Medical University
Last refreshed: 18 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06041399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing